TechforCann, Europe's Cannabis Tech Accelerator, Raises $3 Million

Medical cannabis tech accelerator TechforCann Europe announced this week that it raised 2.5 million euros ($3 million) from Malta Enterprise, the island's governmental innovation agency.

The organization will seek to support early stage entrepreneurs in the European medical cannabis market, which is expected to reach more than $36 billion in sales by 2027, growing at a CAGR of almost 30%.

“At TechforCann Europe we believe that technology can address industry challenges that remain a barrier of entry to the biotech, pharma and high-tech sectors to enable growth,” CEO Lilac Mandeles told Benzinga.

“The European cannabis market is mainly for medical use and includes specific regulatory and industry-challenging requirements,” she added.

According to Mandeles, TechforCann’s goal is to “identify and lead the next breakthrough startups to success, focusing on early-stage start-ups that answer industry challenges.”

TechforCann Europe was created by Israel-based entrepreneurs Mandeles and Yona Cymerman.

Mandeles is a former pharmaceutical executive with experience at J&J, Lilly and Teva.

Cymerman co-founded a medical cannabis business development agency in Israel and ran her own strategic marketing firm for 12 years.

The first cohort of the accelerator is expected to get underway by September 2021.

Encuentra nuestro contenido en Español en El Planteo:

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechCannabisNewsFinancingMarketsGeneralEuropeisraelmedical cannabis
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.